in early 2014, when a Chinese team created gene-edited cynomolgus monkeys by injecting CRISPR into one-cell embryos, much like the method used in mice one year earlier. In this study, the scientists programmed CRISPR to simultaneously target two genes: one associated with severe combined immunodeficiency in humans, the other associated with obesity, both of which have clear implications for human health.
